NEW YORK, NY / ACCESS Newswire / February 23, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

The FDA said weight-loss and diabetes drugs Wegovy and Ozempic are no longer on shortage list. The U.S. Food and Drug ...

These two stocks are poised to crush the market thanks to their outsize growth prospects and dirt cheap valuations.

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

Whether administering vaccines against life-threatening diseases or treating common ailments, paediatricians lay the ...

However, the Vanguard S&P 500 Growth ETF isn't the best performer in the Vanguard family so far in 2025. Instead, it's an ETF ...

We recently published a list of Top 10 Stocks to Buy According to Sustainable Insight Capital Management. In this article, we ...

The former Love Island star, 30, embarked on a health and fitness transformation before launching her own nutrition ...

Korea hosts APEC science and technology cooperation assembly in Gyeongju Asia-Pacific nations set to enhance scientific ...

The NoVo Foundation reported to the IRS that it had $545,384,793 in total assets value at the end of 2023. The organization reported $199,397,422 in contributions, gifts and grants paid. It ...

Auchincloss has pledged a root-and-branch overhaul of BP's strategy. The company is in crisis after it revealed profits slumped by a third last year.

The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...